SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated August 27, 2025, reports a transaction in the company's own shares. The filing details a share repurchase executed on August 26, 2025, through the corporate stockbroker Merrill Lynch International. The transaction was conducted pursuant to a non-discretionary agreement entered into on June 4, 2025.
Key Financial Metrics and Transaction Details
- Shares Purchased: 251,452 ordinary shares of 31½ pence each.
- Price Range: Lowest price paid was 1,460.00p; highest price paid was 1,487.50p.
- Average Price: Volume-weighted average price paid was 1,469.66p.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON).
- Treasury Holdings: Following this purchase, GSK holds 243,658,730 ordinary shares in treasury.
- Shares in Issue: 4,071,733,897 ordinary shares (excluding treasury shares).
- Voting Rights: Treasury shares represent 5.98% of total voting rights.
- Cumulative Buyback: Since June 4, 2025, the company has purchased a total of 25,524,347 ordinary shares.
Material Changes and Program Status
The filing confirms the continuation of GSK's existing buyback programme. The purchase of 251,452 shares on August 26 represents a routine execution under the standing agreement with Merrill Lynch International. There are no material changes to the company's financial position, debt, or liquidity reported in this specific filing, as it is limited to the disclosure of the share repurchase activity.
Guidance, Outlook, and Risks
The filing contains a standard cautionary statement regarding forward-looking statements. GSK notes that projections are subject to risks and uncertainties that may cause actual results to differ materially. Investors are directed to the "Risk Factors" section of GSK's Annual Report on Form 20-F for 2024 and the Q2 Results for 2025 for a detailed discussion of these risks. No new guidance or management commentary regarding future financial performance is provided in this document.
Key Facts for Investor Verification
- Verify the total cumulative buyback volume of 25,524,347 shares since June 4, 2025, against previous disclosures.
- Confirm the updated treasury share count of 243,658,730 and the resulting 5.98% voting rights attribution.
- Note that the repurchase price (average 1,469.66p) reflects market conditions on August 26, 2025.
- Review the referenced Form 20-F (2024) and Q2 2025 results for broader context on the company's financial health and risk profile.